Health Care & Life Sciences » Pharmaceuticals | Hubei Yangfan Holding Co. Ltd.

Hubei Yangfan Holding Co. Ltd. A | Balance Sheet

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
106,588.00
13,367.20
3,055.50
445.20
2,393.70
Total Accounts Receivable
8,767.90
14,329.40
8,908.40
8,416.10
7,976.20
Inventories
-
9,552.50
12,894.10
6,209.70
-
Other Current Assets
0.00
289.90
335.50
131.10
-
Total Current Assets
115,355.80
37,539.00
25,193.40
15,202.10
10,369.90
Net Property, Plant & Equipment
41,893.30
40,462.10
39,723.60
34,401.90
30,163.80
Intangible Assets
14,832.60
14,478.00
14,123.50
13,768.90
13,414.30
Other Assets
-
-
36.00
-
-
Total Assets
172,103.90
92,546.60
79,134.60
63,809.90
53,948.10
ST Debt & Current Portion LT Debt
140,118.10
-
-
-
-
Accounts Payable
7,613.20
17,467.90
9,175.00
5,524.90
1,207.00
Income Tax Payable
607.30
1,585.60
1,005.80
671.10
1,056.00
Other Current Liabilities
5,789.90
51,793.90
46,265.40
31,115.70
29,809.80
Total Current Liabilities
154,128.50
70,847.50
56,446.10
37,311.70
32,072.90
Provision for Risks & Charges
-
-
171.70
912.30
1,144.10
Deferred Taxes
2,345.50
2,240.50
2,191.00
1,753.30
2,155.60
Other Liabilities
-
198.70
-
-
-
Total Liabilities
156,496.10
73,354.20
58,866.90
40,414.20
35,372.50
Common Equity (Total)
3,287.10
5,456.80
5,643.70
8,853.70
5,993.00
Total Shareholders' Equity
3,287.10
5,456.80
5,643.70
8,853.70
5,993.00
Total Equity
14,807.80
18,392.40
19,467.70
22,595.70
17,775.50
Liabilities & Shareholders' Equity
172,103.90
92,546.60
79,134.60
63,809.90
53,948.10
Accumulated Minority Interest
11,520.70
12,935.60
13,823.90
13,741.90
11,782.60
Non-Equity Reserves
800.00
800.00
800.00
800.00
800.00

About Hubei Yangfan Holding Co.

View Profile
Address
22/F, Tower B, Asian Trading Plaza
Wuhan Hubei 430070
China
Employees -
Website http://www.spring.com.cn
Updated 07/08/2019
Hubei Yangfan Holding Co., Ltd. engages in the development and investment of businesses. It also involves in the manufacture and sale of pharmaceutical and biological products as well as engage in the provision of consulting services. The company was founded on November 20, 1997 and is headquartered in Wuhan, China.